These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20529799)

  • 1. Cerebellar assessment for patients receiving high-dose cytarabine: a standardized approach to nursing assessment and documentation.
    Brown C
    Clin J Oncol Nurs; 2010 Jun; 14(3):371-3. PubMed ID: 20529799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and Evaluation 
of a High-Dose Cytarabine Neurologic Assessment Tool.
    Szoch S; Snow Kaiser K
    Clin J Oncol Nurs; 2015 Jun; 19(3):270-2. PubMed ID: 26000577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chemotherapy and infusion therapy flow sheet for outpatient oncology settings.
    Spath ML; Rimkus CF; Saenz DA
    Oncol Nurs Forum; 1998; 25(1):129-35. PubMed ID: 9460780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of 1-beta-D-arabinofuranosylcytosine-beta-2'-deoxythioguanosine combination chemotherapy.
    Rao PN; Freireich EJ; Bodey GP; Gottlieb JA; Smith ML
    Cancer Res; 1974 Oct; 34(10):2539-43. PubMed ID: 4472144
    [No Abstract]   [Full Text] [Related]  

  • 6. Clustering of adverse drug events: analysis of risk factors for cerebellar toxicity with high-dose cytarabine.
    Jolson HM; Bosco L; Bufton MG; Gerstman BB; Rinsler SS; Williams E; Flynn B; Simmons WD; Stadel BV; Faich GA
    J Natl Cancer Inst; 1992 Apr; 84(7):500-5. PubMed ID: 1545440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy of primary cerebral lymphoma].
    Delwail V; Bataille B
    Neurochirurgie; 1997; 43(6):380-4. PubMed ID: 9706617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Observation and care in high-dose cytarabine treatment of acute myelogenous leukemia].
    Xi YR; Tu YL; Zhao XH
    Zhonghua Hu Li Za Zhi; 1996 Nov; 31(11):653-5. PubMed ID: 9304928
    [No Abstract]   [Full Text] [Related]  

  • 9. A chemotherapy standard order form: preventing errors.
    Opfer KB; Wirtz DM; Farley K
    Oncol Nurs Forum; 1999; 26(1):123-8. PubMed ID: 9921575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia.
    Schmitt K; Zoubek A; Schwarz R; Tulzer G; Koller E; Krieger O; Lutz D; Gadner H
    Med Pediatr Oncol; 1996 Apr; 26(4):254-7. PubMed ID: 8600337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of medical, surgical and oncology patients' descriptions of pain and nurses' documentation of pain assessments.
    Camp LD; O'Sullivan PS
    J Adv Nurs; 1987 Sep; 12(5):593-8. PubMed ID: 2447139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nursing care of patients receiving high-dose, continuous-infusion interleukin-2 with pulse dose and famotidine.
    Tyre CC; Quan W
    Clin J Oncol Nurs; 2007 Aug; 11(4):513-9. PubMed ID: 17723964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study.
    Winkelman MD; Hines JD
    Ann Neurol; 1983 Nov; 14(5):520-7. PubMed ID: 6651239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell transplantation after salvage therapy with high-dose cytarabine and amsacrine in adults with high-risk leukaemia.
    Tauro S; Shankaranarayana P; Nitu-Whalley IC; Duncan N; Begum G; Craig JI; Marcus RE; Craddock CF; Mahendra P
    Bone Marrow Transplant; 2003 Aug; 32(3):273-8. PubMed ID: 12858198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and documentation of patients' nutritional status: perceptions of registered nurses and their chief nurses.
    Persenius MW; Hall-Lord ML; Bååth C; Larsson BW
    J Clin Nurs; 2008 Aug; 17(16):2125-36. PubMed ID: 18510576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute leukemia with amsacrine and high-dose cytarabine.
    Arlin ZA; Gaddipati J; Ahmed T; Mittelman A; Friedland M; Rieber E
    Cancer Treat Rep; 1985 Sep; 69(9):1001-2. PubMed ID: 3839713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
    Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive interdisciplinary chemotherapy teaching documentation flowsheet.
    Steele S; Carruth AK
    Oncol Nurs Forum; 1997 Jun; 24(5):907-11. PubMed ID: 9201743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a comprehensive nursing/toxicity assessment form.
    Allaster RM; Frayne BK; Malpage AS; Smuck BL; Studzienny LG
    Oncol Nurs Forum; 1996 Sep; 23(8):1317-24. PubMed ID: 8883077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of a quality assurance review: development of a documentation tool for chemotherapy administration.
    Pevny V
    Oncol Nurs Forum; 1993 Apr; 20(3):535-41. PubMed ID: 8497421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.